Literature DB >> 8660045

Effects on growth of single short courses of fluoroquinolones.

D B Bethell1, T T Hien, L T Phi, N P Day, H Vinh, N M Duong, N V Len, L V Chuong, N J White.   

Abstract

The aim of the study was to document the effects of short courses of fluoroquinolones given during an outbreak of multidrug resistant typhoid fever in southern Viet Nam on the growth of children over a period of two years. In a prospective cohort study, 326 Vietnamese children aged between 1 and 14 years were followed up for two years after receiving either ciprofloxacin (70 mg/kg given over 7 d) (n = 173) or ofloxacin (45-50 mg/kg given over 3-5 d) (n = 153) for suspected typhoid fever. Growth velocity and weight for height were compared with an age matched control group of children from the same locality (n = 223) who had not contracted typhoid or received any fluoroquinolones. In the ofloxacin and ciprofloxacin treated patients there was no evidence of acute joint toxicity, nor of any joint symptoms attributable to either of the fluoroquinolones. There was no difference in expected weight for height measurements between the three groups of children over the two year period. During the first year, height velocity in ciprofloxacin treated children was greater than in either ofloxacin treated children or untreated controls. Height velocity in the latter two groups was not significantly different. After two years height velocity was similar in the three groups. The results support the use of short course fluoroquinolone treatment in childhood typhoid, especially when caused by strains resistant to other antibiotics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8660045      PMCID: PMC1511581          DOI: 10.1136/adc.74.1.44

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  19 in total

1.  Risk/benefit analysis of quinolone use in children: the effect on diarthrodial joints.

Authors:  F Maggiolo; S Caprioli; F Suter
Journal:  J Antimicrob Chemother       Date:  1990-10       Impact factor: 5.790

2.  Spread of multiresistant Salmonella typhi.

Authors: 
Journal:  Lancet       Date:  1990-10-27       Impact factor: 79.321

3.  Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations.

Authors:  R Stahlmann; H J Merker; N Hinz; I Chahoud; J Webb; W Heger; D Neubert
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

4.  Can small daily doses of antibiotics prevent the cycle of diarrhea, malabsorption, and malnutrition in children?

Authors:  N Hirschhorn
Journal:  Am J Clin Nutr       Date:  1971-07       Impact factor: 7.045

5.  Juvenile canine drug-induced arthropathy: clinicopathological studies on articular lesions caused by oxolinic and pipemidic acids.

Authors:  A Gough; N J Barsoum; L Mitchell; E J McGuire; F A de la Iglesia
Journal:  Toxicol Appl Pharmacol       Date:  1979-10       Impact factor: 4.219

6.  A randomized comparative study of fleroxacin and ceftriaxone in enteric fever.

Authors:  T H Tran; M D Nguyen; D H Huynh; T T Nguyen; S D To; T P Le; K Arnold
Journal:  Trans R Soc Trop Med Hyg       Date:  1994 Jul-Aug       Impact factor: 2.184

Review 7.  Use of quinolones in pediatric patients.

Authors:  D Adam
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

8.  Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.

Authors:  J M Tanner; R H Whitehouse
Journal:  Arch Dis Child       Date:  1976-03       Impact factor: 3.791

9.  Histologic and histochemical changes in articular cartilages of immature beagle dogs dosed with difloxacin, a fluoroquinolone.

Authors:  J E Burkhardt; M A Hill; W W Carlton; J W Kesterson
Journal:  Vet Pathol       Date:  1990-05       Impact factor: 2.221

Review 10.  Fluoroquinolones in the treatment of cystic fibrosis: a critical appraisal.

Authors:  M LeBel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

View more
  10 in total

Review 1.  Tolerability of fluoroquinolone antibiotics. Past, present and future.

Authors:  P Ball; G Tillotson
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

2.  Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever.

Authors:  D B Bethell; N P Day; N M Dung; C McMullin; H T Loan; D T Tam; L T Minh; N T Linh; N Q Dung; H Vinh; A P MacGowan; L O White; N J White
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

3.  Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever.

Authors:  Christopher M Parry; Vo Anh Ho; Le Thi Phuong; Phan Van Be Bay; Mai Ngoc Lanh; Le Thanh Tung; Nguyen Thi Hong Tham; John Wain; Tran Tinh Hien; Jeremy J Farrar
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

Review 4.  Safety Concerns Surrounding Quinolone Use in Children.

Authors:  Karisma Patel; Jennifer L Goldman
Journal:  J Clin Pharmacol       Date:  2016-03-28       Impact factor: 3.126

Review 5.  Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Authors:  John A Crump; Maria Sjölund-Karlsson; Melita A Gordon; Christopher M Parry
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

Review 6.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

7.  A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children.

Authors:  Ha Vinh; Vo Thi Cuc Anh; Nguyen Duc Anh; James I Campbell; Nguyen Van Minh Hoang; Tran Vu Thieu Nga; Nguyen Thi Khanh Nhu; Pham Van Minh; Cao Thu Thuy; Pham Thanh Duy; Le Thi Phuong; Ha Thi Loan; Mai Thu Chinh; Nguyen Thi Thu Thao; Nguyen Thi Hong Tham; Bui Li Mong; Phan Van Be Bay; Jeremy N Day; Christiane Dolecek; Nguyen Phu Huong Lan; To Song Diep; Jeremy J Farrar; Nguyen Van Vinh Chau; Marcel Wolbers; Stephen Baker
Journal:  PLoS Negl Trop Dis       Date:  2011-08-02

Review 8.  Ciprofloxacin safety in paediatrics: a systematic review.

Authors:  Abiodun Adefurin; Helen Sammons; Evelyne Jacqz-Aigrain; Imti Choonara
Journal:  Arch Dis Child       Date:  2011-07-23       Impact factor: 3.791

9.  Oxidative stress induced by fluoroquinolones on treatment for complicated urinary tract infections in Indian patients.

Authors:  V Talla; Pr Veerareddy
Journal:  J Young Pharm       Date:  2011-10

10.  Population pharmacokinetics of intravenous and oral ciprofloxacin in children to optimize dosing regimens.

Authors:  D Hirt; M Oualha; B Pasquiers; S Blanot; R Rubinstazjn; C Glorion; S El Messaoudi; D Drummond; V Lopez; J Toubiana; A Béranger; Sana Boujaafar; Yi Zheng; Carmen Capito; S Winter; P L Léger; R Berthaud; Inès Gana; F Foissac; J M Tréluyer; N Bouazza; S Benaboud
Journal:  Eur J Clin Pharmacol       Date:  2021-06-23       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.